Pentoxifylline and its applications in dermatology
- PMID: 25396144
- PMCID: PMC4228656
- DOI: 10.4103/2229-5178.142528
Pentoxifylline and its applications in dermatology
Abstract
Pentoxifylline is a methyl-xanthine derivative with many anti inflammatory effects. Pentoxifylline has been found to be effective for many dermatological as well as non-dermatological conditions. It has been used both as primary drug as well as adjuvant and is a safe and relatively cost-effective alternative drug. In this article, we review the literature and highlight various important aspects of pentoxifylline.
Keywords: Cost effective; methyl xanthine; pentoxifylline; safe.
Conflict of interest statement
Figures
Similar articles
-
Pentoxifylline in dermatology.J Cosmet Dermatol. 2023 Feb;22(2):410-417. doi: 10.1111/jocd.15445. Epub 2022 Oct 31. J Cosmet Dermatol. 2023. PMID: 36208009 Review.
-
Pentoxifylline use in dermatology.Inflamm Allergy Drug Targets. 2012 Dec;11(6):422-32. doi: 10.2174/187152812803590028. Inflamm Allergy Drug Targets. 2012. PMID: 22680624 Review.
-
The xanthine derivative 1-(5'-oxohexyl)-3-methyl-7-propyl xanthine (HWA 285) enhances the actions of adenosine.Acta Pharmacol Toxicol (Copenh). 1986 Mar;58(3):187-92. doi: 10.1111/j.1600-0773.1986.tb00093.x. Acta Pharmacol Toxicol (Copenh). 1986. PMID: 3012941
-
Pentoxifylline, a methyl xanthine derivative, reduces peritoneal adhesions and increases peritoneal fibrinolysis in rats.Tohoku J Exp Med. 2006 Jul;209(3):249-55. doi: 10.1620/tjem.209.249. Tohoku J Exp Med. 2006. PMID: 16778372
-
Pentoxifylline: a drug with wide spectrum applications in dermatology.Dermatol Online J. 2008 Nov 15;14(11):2. Dermatol Online J. 2008. PMID: 19094840 Review.
Cited by
-
Intralesional Pentoxifylline Injection Versus Triamcinolone Acetonide in Treating localized Alopecia Areata: A Comparative Study.J Clin Aesthet Dermatol. 2023 Nov;16(11):26-30. J Clin Aesthet Dermatol. 2023. PMID: 38076656 Free PMC article.
-
Exploring pentoxifylline as an alternative treatment for dexamethasone in diabetic patients with COVID-19: a randomized controlled trial.Eur J Med Res. 2025 Jul 1;30(1):540. doi: 10.1186/s40001-025-02678-1. Eur J Med Res. 2025. PMID: 40598604 Free PMC article. Clinical Trial.
-
Current Insights and Molecular Docking Studies of the Drugs under Clinical Trial as RdRp Inhibitors in COVID-19 Treatment.Curr Pharm Des. 2022;28(46):3677-3705. doi: 10.2174/1381612829666221107123841. Curr Pharm Des. 2022. PMID: 36345244
-
Xanthine scaffold: scope and potential in drug development.Heliyon. 2018 Oct 3;4(10):e00829. doi: 10.1016/j.heliyon.2018.e00829. eCollection 2018 Oct. Heliyon. 2018. PMID: 30302410 Free PMC article. Review.
-
Pentoxifylline/Chitosan Films on Wound Healing: In Vitro/In Vivo Evaluation.Pharmaceutics. 2023 Mar 31;15(4):1122. doi: 10.3390/pharmaceutics15041122. Pharmaceutics. 2023. PMID: 37111607 Free PMC article.
References
-
- Smith RV, Waller ES, Doluisio JT, Bauza MT, Puri SK, Ho I, et al. Pharmacokinetics of orally administered pentoxifylline in humans. J Pharm Sci. 1986;75:47–52. - PubMed
-
- Ward A, Clissold SP. Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs. 1987;34:50–97. - PubMed
-
- Samlaska CP, Winfield EA. Pentoxifylline. J Am Acad Dermatol. 1994;30:603–21. - PubMed
-
- Strieter RM, Remick DG, Ward PA, Spengler RN, Lynch JP, 3rd, Larrick J, et al. Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline. Biochem Biophys Res Commun. 1988;155:1230–6. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources